Eruptive pseudoangiomatosis induced by gestodene in an oral contraceptive

Boaz Amichai, Aneta Lazarov*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


We describe a case of eruptive pseudoangiomatosis triggered by the oral contraceptive Minulet® containing gestodene and ethinyloestradiol. A possible immunological mechanism in the induction of the skin lesions is suggested by the histopathological findings and a positive macrophage migration inhibition factor (MIF) test for the progesterone components in Minulet®.

Original languageEnglish
Pages (from-to)259-261
Number of pages3
JournalJournal of the European Academy of Dermatology and Venereology
Issue number3
StatePublished - 1997
Externally publishedYes


  • Eruptive pseudoangiomatosis
  • Gestodene
  • Minulet®
  • Oral contraceptive


Dive into the research topics of 'Eruptive pseudoangiomatosis induced by gestodene in an oral contraceptive'. Together they form a unique fingerprint.

Cite this